Kezdőlap › Mellrák › Észak-Karolina › Durham
Mellrák klinikai vizsgálatok: Durham, NC
64 Mellrák vizsgálat keres résztvevőket Durham és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
The Vanguard Study: Testing a New Way to Screen for Cancer
Toborzás folyamatbanEgészséges önkéntesek is jelentkezhetnek
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
A Study of PHST001 in Advanced Solid Tumors
Toborzás folyamatban1. fázis
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Toborzás folyamatban1/2. fázis
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Toborzás folyamatban3. fázis
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Toborzás folyamatban2. fázisEgészséges önkéntesek is jelentkezhetnek
- University of North Carolina, Chapel Hill · 10 mérföldre
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Toborzás folyamatban2. fázis
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
Toborzás folyamatbanMegfigyeléses tanulmány
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Toborzás folyamatban1. fázis
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- University of North Carolina, Chapel Hill · 10 mérföldre
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Toborzás folyamatban2. fázis
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Toborzás folyamatban3. fázis
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Toborzás folyamatban1. fázis
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Toborzás folyamatban3. fázis
- University of North Carolina Medical Center, Chapel Hill · 10 mérföldre
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Toborzás folyamatban2. fázis
- University of North Carolina Medical Center, Chapel Hill · 10 mérföldre
Identifying Patterns in the Breath of Individuals With Breast Cancer
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Toborzás folyamatban2. fázis
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mérföldre
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Toborzás folyamatban2. fázis
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mérföldre
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Toborzás folyamatban3. fázis
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
Toborzás folyamatbanMegfigyeléses tanulmány
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Toborzás folyamatban1/2. fázis
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Toborzás folyamatban1. fázis
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Toborzás folyamatban1/2. fázis
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Toborzás folyamatban3. fázis
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
Toborzás folyamatban2. fázis
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
Toborzás folyamatban2. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Toborzás folyamatban3. fázis
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mérföldre
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
Toborzás folyamatbanEgészséges önkéntesek is jelentkezhetnek
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Toborzás folyamatban2. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
Optimizing Surgical Decisions in Young Adults With Breast Cancer
Toborzás folyamatban
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
Toborzás folyamatbanMegfigyeléses tanulmány
- University of North Carolina, Chapel Hill · 10 mérföldre
Weight Management After Cancer for Survivors in Rural Communities
Toborzás folyamatban
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
Toborzás folyamatban
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Toborzás folyamatban2/3. fázis
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Toborzás folyamatban
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Toborzás folyamatban2. fázis
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
Toborzás folyamatban
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
Toborzás folyamatban1. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Toborzás folyamatban
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mérföldre
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Toborzás folyamatban
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
Toborzás folyamatbanMegfigyeléses tanulmány
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mérföldre
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Toborzás folyamatban3. fázis
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
Toborzás folyamatban1. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
Toborzás folyamatban2. fázisEgészséges önkéntesek is jelentkezhetnek
- The University of North Carolina, Chapel Hill · 10 mérföldre
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
Toborzás folyamatbanMegfigyeléses tanulmány
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
Toborzás folyamatban2. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
Toborzás folyamatban
- University of North Carolina, Chapel Hill · 10 mérföldre
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Toborzás folyamatban2. fázis
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mérföldre
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Toborzás folyamatban2. fázis
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
Toborzás folyamatban2. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
Toborzás folyamatban2. fázis
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Toborzás folyamatban
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Toborzás folyamatban1/2. fázis
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Toborzás folyamatbanMegfigyeléses tanulmány
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Toborzás folyamatban2. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Toborzás folyamatban1. fázis
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
Toborzás folyamatban
- UNC Cancer Hospital, Chapel Hill · 10 mérföldre
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
Toborzás folyamatban
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Toborzás folyamatban
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
Toborzás folyamatban
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
BREAST Choice Decision Tool R21 - AIM2
Toborzás folyamatbanEgészséges önkéntesek is jelentkezhetnek
- The University of North Carolina, Chapel Hill · 10 mérföldre
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Toborzás folyamatban
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Toborzás folyamatbanMegfigyeléses tanulmány
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mérföldre
UNC Pleural Fluid Registry
Toborzás folyamatbanMegfigyeléses tanulmány
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
Mellrák vizsgálatok más városokban
- New York City, NY136 tanulmány
- Houston, TX126 tanulmány
- Boston, MA112 tanulmány
- Nashville, TN81 tanulmány
- Los Angeles, CA73 tanulmány
- Edison, NJ68 tanulmány
- St. Louis, MO64 tanulmány
- Queens, NY64 tanulmány
- Chicago, IL59 tanulmány
- Philadelphia, PA56 tanulmány
- Dallas, TX55 tanulmány
- Arlington, VA47 tanulmány
Egyéb vizsgálatok: Durham
- Rák (minden típus)58 tanulmány
- Nem kis sejtes tüdőrák39 tanulmány
- Multiplex mielóma37 tanulmány
- Akut mieloid leukémia33 tanulmány
- Áttétes rák33 tanulmány
- Prosztatarák32 tanulmány
- Tüdőrák32 tanulmány
- Kolorektális rák28 tanulmány
- Petefészekrák27 tanulmány
- Krónikus limfocitás leukémia27 tanulmány
- Szívelégtelenség26 tanulmány
- Hasnyálmirigyrák24 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 6.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.